Cis-diamminedichloroplatinum in the treatment of advanced epidermoid carcinoma of the penis: A Southwest Oncology Group study

R. G. Gagliano, B. A. Blumenstein, E. D. Crawford, R. L. Stephens, C. A. Coltman, J. J. Costanzi

Research output: Contribution to journalArticlepeer-review

51 Scopus citations


A total of 26 patients with biopsy proved epidermoid carcinoma of the penis (Jackson stage III or IV) with measurable disease, no prior chemotherapy and adequate renal function received 50 mg. per M. cis-diamminedichloroplatinum intravenously on days 1 and 8 of 28-day cycles. There were 4 partial responses (15.4 per cent), with a response duration of 1 to 3 months. The median survival was 4.7 months. This agent cannot be recommended as treatment for advanced epidermoid carcinoma of the penis using this particular dose and schedule.

Original languageEnglish (US)
Pages (from-to)66-67
Number of pages2
JournalJournal of Urology
Issue number1
StatePublished - 1989
Externally publishedYes

ASJC Scopus subject areas

  • Urology

Cite this